O	0	9	Cognition
O	10	12	in
O	13	19	breast
O	20	26	cancer
O	27	36	survivors
O	36	37	:
O	38	39	A
O	40	45	pilot
O	46	51	study
O	52	54	of
B-intervention	55	63	interval
I-intervention	64	67	and
I-intervention	68	78	continuous
I-intervention	79	87	exercise
O	87	88	.

O	89	92	The
O	93	100	current
O	101	106	study
O	107	119	investigated
O	120	123	the
O	124	131	effects
O	132	134	of
O	135	138	two
O	139	147	exercise
O	148	161	interventions
O	162	164	on
O	165	174	cognitive
O	175	183	function
O	184	191	amongst
O	192	198	breast
O	199	205	cancer
O	206	215	survivors
O	215	216	.

O	217	222	Pilot
O	223	233	randomised
O	233	234	-
O	234	244	controlled
O	245	250	trial
O	250	251	.

B-total-participants	252	261	Seventeen
B-eligibility	262	268	female
I-eligibility	269	275	cancer
I-eligibility	276	285	survivors
O	286	287	(
O	287	291	mean
O	291	292	:
B-age	293	295	62
I-age	295	296	.
I-age	296	297	9
I-age	297	298	±
I-age	298	299	7
I-age	299	300	.
I-age	300	306	8years
O	306	307	)
O	308	312	were
O	313	323	randomised
O	324	328	into
O	329	334	three
O	335	341	groups
O	341	342	:
O	343	347	high
O	347	348	-
O	348	357	intensity
O	358	366	interval
O	367	375	training
O	376	377	(
O	377	381	HIIT
O	381	382	,
O	383	384	n
O	384	385	=
B-intervention-participants	385	386	6
O	386	387	)
O	387	388	;
O	389	397	moderate
O	397	398	-
O	398	407	intensity
O	408	418	continuous
O	419	427	training
O	428	429	(
O	429	432	MOD
O	432	433	,
O	434	435	n
O	435	436	=
B-intervention-participants	436	437	5
O	437	438	)
O	438	439	;
O	440	442	or
B-control	443	447	wait
I-control	447	448	-
I-control	448	452	list
I-control	453	460	control
O	461	462	(
O	462	465	CON
O	465	466	,
O	467	468	n
O	468	469	=
B-control-participants	469	470	6
O	470	471	)
O	471	472	.

O	473	476	The
O	477	481	HIIT
O	482	485	and
O	486	489	MOD
O	490	496	groups
O	497	506	exercised
O	507	509	on
O	510	511	a
O	512	517	cycle
O	518	527	ergometer
O	528	533	3days
O	533	534	/
O	534	538	week
O	539	542	for
O	543	545	12
O	545	546	-
O	546	551	weeks
O	551	552	.

O	553	560	Primary
O	561	569	outcomes
O	570	574	were
B-outcome-Measure	575	584	cognitive
I-outcome-Measure	585	593	function
I-outcome-Measure	594	605	assessments
I-outcome-Measure	606	615	utilising
I-outcome-Measure	616	624	CogState
O	624	625	.

O	626	635	Secondary
O	636	644	outcomes
O	645	649	were
B-outcome-Measure	650	657	resting
I-outcome-Measure	658	664	middle
I-outcome-Measure	665	673	cerebral
I-outcome-Measure	674	680	artery
I-outcome-Measure	681	686	blood
I-outcome-Measure	687	691	flow
I-outcome-Measure	692	700	velocity
O	700	701	,
B-outcome-Measure	702	717	cerebrovascular
I-outcome-Measure	718	728	reactivity
O	729	732	and
B-outcome-Measure	733	740	aerobic
I-outcome-Measure	741	748	fitness
I-outcome-Measure	749	750	(
I-outcome-Measure	750	757	VO2peak
I-outcome-Measure	757	758	)
O	758	759	.

O	760	764	Data
O	765	769	were
O	770	778	analysed
O	779	783	with
O	784	791	General
O	792	798	Linear
O	799	804	Mixed
O	805	811	Models
O	812	815	and
O	816	821	Cohen
O	821	822	'
O	822	823	s
O	824	825	d
O	826	832	effect
O	833	838	sizes
O	839	843	were
O	844	854	calculated
O	854	855	.

O	856	859	All
B-total-participants	860	862	17
O	863	875	participants
O	876	879	who
O	880	884	were
O	885	895	randomised
O	896	900	were
O	901	910	available
O	911	914	for
O	915	921	follow
O	921	922	-
O	922	924	up
O	925	933	analysis
O	934	937	and
B-outcome	938	947	adherence
O	948	951	was
O	952	959	similar
O	960	963	for
O	964	968	HIIT
O	969	972	and
O	973	976	MOD
O	977	978	(
B-iv-cont-mean	978	980	78
I-iv-cont-mean	980	981	.
I-iv-cont-mean	981	982	7
O	982	983	±
B-iv-cont-sd	983	985	13
I-iv-cont-sd	985	986	.
I-iv-cont-sd	986	987	2
I-iv-cont-sd	987	988	%
O	989	991	vs
B-iv-cont-mean	992	994	79
I-iv-cont-mean	994	995	.
I-iv-cont-mean	995	996	4
O	996	997	±
B-iv-cont-sd	997	999	12
I-iv-cont-sd	999	1000	.
I-iv-cont-sd	1000	1001	0
I-iv-cont-sd	1001	1002	%
O	1002	1003	;
O	1004	1005	p
O	1005	1006	=
O	1006	1007	0
O	1007	1008	.
O	1008	1010	93
O	1010	1011	)
O	1011	1012	.

O	1013	1021	Although
O	1022	1027	there
O	1028	1032	were
O	1033	1035	no
O	1036	1047	significant
O	1048	1059	differences
O	1060	1062	in
O	1063	1066	the
O	1067	1076	cognitive
O	1077	1080	and
O	1081	1096	cerebrovascular
O	1097	1105	outcomes
O	1105	1106	,
O	1107	1111	HIIT
O	1112	1120	produced
O	1121	1129	moderate
O	1130	1132	to
O	1133	1138	large
O	1139	1147	positive
O	1148	1155	effects
O	1156	1158	in
O	1159	1169	comparison
O	1170	1172	to
O	1173	1176	MOD
O	1177	1180	and
O	1181	1184	CON
O	1185	1188	for
O	1189	1197	outcomes
O	1198	1207	including
B-outcome	1208	1216	episodic
I-outcome	1217	1223	memory
O	1223	1224	,
B-outcome	1225	1232	working
I-outcome	1233	1239	memory
O	1239	1240	,
B-outcome	1241	1250	executive
I-outcome	1251	1259	function
O	1259	1260	,
B-outcome	1261	1269	cerebral
I-outcome	1270	1275	blood
I-outcome	1276	1280	flow
O	1281	1284	and
B-outcome	1285	1300	cerebrovascular
I-outcome	1301	1311	reactivity
O	1311	1312	.

O	1313	1317	HIIT
O	1318	1331	significantly
O	1332	1341	increased
B-outcome	1342	1349	VO2peak
O	1350	1352	by
B-iv-cont-mean	1353	1355	19
I-iv-cont-mean	1355	1356	.
I-iv-cont-mean	1356	1357	3
I-iv-cont-mean	1357	1358	%
O	1359	1360	(
O	1360	1361	d
O	1361	1362	=
O	1362	1363	1
O	1363	1364	.
O	1364	1366	28
O	1366	1367	)
O	1368	1371	and
O	1372	1375	MOD
O	1376	1379	had
O	1380	1381	a
O	1382	1385	non
O	1385	1386	-
O	1386	1397	significant
B-iv-cont-mean	1398	1399	5
I-iv-cont-mean	1399	1400	.
I-iv-cont-mean	1400	1401	6
I-iv-cont-mean	1401	1402	%
O	1403	1404	(
O	1404	1405	d
O	1405	1406	=
O	1406	1407	0
O	1407	1408	.
O	1408	1410	72
O	1410	1411	)
O	1412	1420	increase
O	1420	1421	,
O	1422	1430	compared
O	1431	1433	to
O	1434	1437	CON
O	1438	1443	which
O	1444	1447	had
O	1448	1449	a
B-cv-cont-mean	1450	1451	2
I-cv-cont-mean	1451	1452	.
I-cv-cont-mean	1452	1453	6
I-cv-cont-mean	1453	1454	%
O	1455	1463	decrease
O	1463	1464	.

O	1465	1469	This
O	1470	1475	study
O	1476	1484	provides
O	1485	1496	preliminary
O	1497	1505	evidence
O	1506	1510	that
O	1511	1515	HIIT
O	1516	1519	may
O	1520	1522	be
O	1523	1525	an
O	1526	1535	effective
O	1536	1544	exercise
O	1545	1557	intervention
O	1558	1560	to
O	1561	1568	improve
B-outcome	1569	1578	cognitive
I-outcome	1579	1590	performance
O	1590	1591	,
B-outcome	1592	1607	cerebrovascular
I-outcome	1608	1616	function
O	1617	1620	and
B-outcome	1621	1628	aerobic
I-outcome	1629	1636	fitness
O	1637	1639	in
O	1640	1646	breast
O	1647	1653	cancer
O	1654	1663	survivors
O	1663	1664	.

O	1665	1676	Considering
O	1677	1680	the
O	1681	1687	sample
O	1688	1692	size
O	1693	1695	is
O	1696	1701	small
O	1701	1702	,
O	1703	1708	these
O	1709	1716	results
O	1717	1723	should
O	1724	1726	be
O	1727	1736	confirmed
O	1737	1744	through
O	1745	1751	larger
O	1752	1760	clinical
O	1761	1767	trials
O	1767	1768	.
